Research Article

Antibiofilm Activity of Curcumin and Piperine and Their Synergistic Effects with Antifungals against Candida albicans Clinical Isolates

Table 1

Minimum inhibitory concentrations (MICs) of antifungals and natural substances against C. albicans strains.

IsolatesMinimum inhibitory concentrations (MIC, μg/mL)
AntifungalsNatural substances
AmBNysCloFluCurcuminPiperine

ATCC 900232 (R)64 (R)128 (R)128 (R)128 (L)512 (L)
Ca010.25 (S)1 (S)1 (I)1 (S)16 (M)128 (L)
Ca020.25 (S)32 (R)16 (R)128 (R)32 (M)512 (L)
Ca032 (I)16 (R)32 (R)128 (R)32 (M)32 (M)
Ca040.5 (S)0.5 (S)16 (R)0.5 (S)256 (L)512 (L)
Ca054 (I)8 (R)64 (R)128 (R)128 (L)256 (L)
Ca0664 (R)64 (R)16 (R)256 (L)1024 (N)
Ca0764 (R)128 (R)0.125 (S)128 (R)0.125 (Si)512 (L)
Ca081 (S)4 (R)8 (R)64 (M)128 (L)
Ca091 (S)2 (I)32 (R)4 (S)16 (M)32 (M)
Ca1064 (R)64 (R)4 (R)64 (R)128 (M)128 (L)
Ca110.25 (S)0.5 (S)32 (R)8 (S)256 (L)32 (M)
Ca121 (S)0.5 (S)2 (I)16 (I)256 (L)128 (L)
Ca1364 (R)128 (R)2 (I)128 (R)16 (M)128 (L)
Ca141 (S)32 (R)32 (R)32 (I)256 (L)512 (L)
Ca1532 (R)4 (I)64 (R)32 (I)64 (M)1024 (N)
Ca1632 (R)64 (R)16 (R)8 (S)16 (M)256 (L)
Ca170.25 (S)1 (I)1 (S)256 (L)128 (L)
Ca1832 (R)32 (R)64 (R)64 (R)128 (L)256 (L)
Ca1932 (R)4 (I)8 (R)16 (I)256 (L)512 (L)
Ca200.125 (S)1 (S)16 (R)2 (S)8 (Si)64 (M)
MIC5032321664128256
MIC90646432128256512

MIC: minimum inhibitory concentration (μg/mL); AmB: amphotericin B; Nys: nystatin; Clo: clotrimazole; Flu: fluconazole; Cur: curcumin; Pip: piperine; C.a: Candida albicans; ATCC 9002: American Type Culture Collection strain; (—): MIC of antifungals up to 128 μg/mL; R: resistant; I: intermediate; S: susceptible; Si: significant activity; M: moderate activity; L: low activity; N: no activity; MIC50: concentration required to inhibit 50% of isolates; MIC90: concentrations required to inhibit 90% of isolates; the criteria (reference) used to define the activity of natural compounds as significant (Si), moderate (M), or low (L), or no activity (N) were defined as previously described [9].